Clinical Trials Browser

Phase 1/2 × Melanoma × GV1001 peptide × Clear all

NCT01247623 2014-11-05

Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma

Phase 1/2 Completed

Melanoma